Strive, Inc.

NasdaqGM:ASST Stock Report

Market Cap: US$1.3b

Strive Past Earnings Performance

Past criteria checks 0/6

Strive's earnings have been declining at an average annual rate of -2993.5%, while the Medical Equipment industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 63.4% per year.

Key information

-2,993.51%

Earnings growth rate

88.60%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate63.36%
Return on equity-63.33%
Net Margin-9,932.05%
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Seeking Alpha Dec 03

Strive: Bitcoin Treasury - Opportunity Or Trap?

Summary I rate Strive Asset Management a Strong Sell due to extreme losses, speculative business model, and lack of earnings. Q3 results were disastrous: -$192.3 million GAAP net loss, no dividend, and a 15.19% short interest signal deep skepticism. ASST's acquisition of Semler Scientific to enter preventative healthcare raises serious questions about strategic coherence and management credibility. With a -94% decline since inception, ASST is a high-risk, speculative play driven by Bitcoin volatility and unproven management. Read the full article on Seeking Alpha

Revenue & Expenses Breakdown

How Strive makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:ASST Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 267-698190
31 Dec 256-425140
30 Sep 256-223120
30 Jun 255-24150
31 Mar 254-23160
31 Dec 244-22170
31 Dec 232-17110

Quality Earnings: ASST is currently unprofitable.

Growing Profit Margin: ASST is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if ASST's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare ASST's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ASST is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.8%).


Return on Equity

High ROE: ASST has a negative Return on Equity (-63.33%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/01 06:51
End of Day Share Price 2026/06/01 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Strive, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fedor ShabalinB. Riley Securities, Inc.
Michael ColonneseH.C. Wainwright & Co.
Matthew GalinkoMaxim Group